These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24705030)

  • 1. The social cost of rheumatoid arthritis in Italy: the results of an estimation exercise.
    Turchetti G; Bellelli S; Mosca M
    Reumatismo; 2014 Mar; 65(6):271-7. PubMed ID: 24705030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.
    Hamuryudan V; Direskeneli H; Ertenli I; Inanc M; Karaaslan Y; Oksel F; Ozbek S; Pay S; Terzioglu E; Balkan Tezer D; Hacibedel B; Akkoc N
    Clin Exp Rheumatol; 2016; 34(6):1033-1037. PubMed ID: 27749224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy.
    Della Rossa A; Neri R; Talarico R; Doveri M; Consensi A; Salvadori S; Lorenzoni V; Turchetti G; Bellelli S; Cazzato M; Bazzichi L; Monicelli P; Moscardini S; Bombardieri S
    Clin Rheumatol; 2010 Jan; 29(1):71-81. PubMed ID: 19806287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target?
    Modena V; Bianchi G; Roccatello D
    Autoimmun Rev; 2013 Jun; 12(8):835-8. PubMed ID: 23219766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter cost-of-illness study on rheumatoid arthritis in Italy.
    Leardini G; Salaffi F; Montanelli R; Gerzeli S; Canesi B
    Clin Exp Rheumatol; 2002; 20(4):505-15. PubMed ID: 12175106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients.
    Mennini FS; Marcellusi A; Gitto L; Iannone F
    Clin Drug Investig; 2017 Apr; 37(4):375-386. PubMed ID: 28074337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual costs of rheumatoid arthritis in Turkey.
    Malhan S; Akbulut LA; Bodur H; Tulunay CF
    Rheumatol Int; 2010 Mar; 30(5):637-41. PubMed ID: 19582459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H; Luan L; Yang K; Li SC
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database.
    Baser O; Burkan A; Baser E; Koselerli R; Ertugay E; Altinbas A
    Rheumatol Int; 2013 Oct; 33(10):2577-84. PubMed ID: 23708559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs in rheumatology: results and lessons learned from the 'Hannover Costing Study'.
    Hülsemann JL; Ruof J; Zeidler H; Mittendorf T
    Rheumatol Int; 2006 Jun; 26(8):704-11. PubMed ID: 16261384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?
    Davies LM; Fargher EA; Tricker K; Dawes P; Scott DL; Symmons D
    Ann Rheum Dis; 2007 May; 66(5):658-63. PubMed ID: 17124249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
    Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
    Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of rheumatoid arthritis.
    Allaire SH; Prashker MJ; Meenan RF
    Pharmacoeconomics; 1994 Dec; 6(6):513-22. PubMed ID: 10155281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study.
    Roodenrijs NMT; Welsing PMJ; van der Goes MC; Tekstra J; Lafeber FPJG; Jacobs JWG; van Laar JM
    Rheumatology (Oxford); 2021 Oct; 60(10):4681-4690. PubMed ID: 33502493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNFalpha treatment in Italian patients.
    Benucci M; Li Gobbi F; Sabadini L; Saviola G; Baiardi P; Manfredi M
    Int J Immunopathol Pharmacol; 2009; 22(4):1147-52. PubMed ID: 20074482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project.
    Hallert E; Husberg M; Kalkan A; Skogh T; Bernfort L
    Scand J Rheumatol; 2014; 43(3):177-83. PubMed ID: 24354438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of rheumatoid arthritis (RA) biotherapies in France.
    Maravic M
    Joint Bone Spine; 2010 Jul; 77(4):319-24. PubMed ID: 20493751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.